País: Tanzania
Idioma: inglés
Fuente: Tanzania Medicinces & Medical Devices Authority
Midazolam Injection BP 5 mg/ml
Intas Pharmaceuticals Limited, INDIA
Hypnotics and sedatives drugs
Midazolam Injection BP 5 mg/ml
5mg/ml
Solution for injection
Intas Pharmaceuticals Limited, INDIA
Physical description: A clear colorless to pale yellow solution filled in a clear glass ampoule. When examined under suitable conditions of visibility it should conditions of visibility it should be practically free from foreign particles; Local technical representative: PHARMAJEN LIMITED (61840)
Registered/Compliant
2022-12-05
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Midazolam Injection BP 5 mg/ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Midazolam (as hydrochloride) 5 mg See section 6.1 for List of excipients 3. PHARMACEUTICAL FORM Dosage form: Solution for Injection/infusion Midazolam Injection is a clear colorless to pale yellow solution filled in a clear glass ampoule. When examined under suitable conditions of visibility it should be practically free from foreign particles. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Midazolam is a short acting sleep-inducing active substance that is indicated: _In adults: _ • CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia. • ANAESTHESIA - Premedication before induction of anaesthesia - Induction of anaesthesia - As a sedative component in combined anaesthesia • SEDATION IN INTENSIVE CARE UNITS _In children: _ • CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia. • ANAESTHESIA - Premedication before induction of anaesthesia • SEDATION IN INTENSIVE CARE UNITS 4.2 POSOLOGY AND METHOD OF ADMINISTRATION STANDARD DOSAGE Midazolam is a potent sedative agent that requires titration and slow administration. Titration is strongly recommended to safely obtain the desired level of sedation according to the clinical need, physical status, age and concomitant medication. In adults over 60 years, debilitated or chronically ill patients and paediatric patients, dose should be determined with caution and risk factors related to each patient should be taken into account. Standard dosages are provided in the table below. Additional details are provided in the text following the table. INDICATION ADULTS < 60 Y ADULTS ≥ 60Y / DEBILITATED OR CHRONICALLY ILL CHILDREN Conscious sedation i.v. Initial dose: 2 – 2.5 mg Titration doses: 1 mg Total dose: 3.5–7.5 mg i.v. Initial dose: 0.5–1 mg Titration doses: 0.5–1 mg Total dose: <3. Leer el documento completo